Pfizer Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Pfizer Ltd with respect to news appearing in The Economic Times on August 08, 2016 titled "REGULATORS SPOT DEFICIENCIES - Pfizer Halts Production at Chennai Unit."Pfizer Ltd response is enclosed. Clarification sought from Pfizer Ltd
The Exchange has sought clarification from Pfizer Ltd with respect to news article appearing in The Economic Times on August 08, 2016 titled "REGULATORS SPOT DEFICIENCIES - Pfizer Halts Production at Chennai Unit."The reply is awaited. Pfizer adds to list of drugmakers under lens for deviating from good manufacturing practices
The USFDA and MHRA submitted their inspection observation reports, which Pfizer said it has reviewed in depth. Results Press Release for June 30, 2016
Pfizer Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 2016 Updates
Pfizer Ltd has informed BSE that a teleconference call has been scheduled with the analysts on August 08, 2016, at 4.00 p.m. to discuss the Company's financial performance for the quarter ended June 30, 2016.
Pfizer Q1 net rises 6% to Rs80 crore
Pfizer standalone total income from operations rose to Rs501 crore as against Rs483 crore for the same period a year ago Announces Q1 results (Standalone) & Limited Review Report (Standalone) for the Quarter ended June 30, 2016
Pfizer Ltd has announced the following Unaudited Standalone results for the quarter ended June 30, 2016:The Company has posted a net profit of Rs. 800.40 million for the quarter ended June 30, 2016 as compared to Rs. 751.70 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 5002.80 million for the quarter ended June 30, 2015 to Rs. 5227.70 million for the quarter ended June 30, 2016. MSF and Pfizer battle over patent application for life-saving pneumonia vaccine
MSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious and predictable. Q1 results on August 05, 2016
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on Friday, August 05, 2016, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter and three months ended June 30, 2016 (Q1).Further, the Trading Window for trading in the Equity shares of the Company will be closed from July 27, 2016 to August 07, 2016, both days inclusive. Shareholding for the Period Ended June 30, 2016
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here